Key result
Cholesterol embolism syndromes cause devastating multi-organ infarction, making anticoagulants and thrombolytics relatively contraindicated.
Case Report (n=4)
Answers are grounded in this paper and cite their sources.
Cholesterol embolism is a devastating, multi-organ syndrome in ICU patients where anticoagulation and thrombolysis are relatively contraindicated.
Four case reports are presented, followed by a discussion of the acute, potentially life-threatening manifestations of the cholesterol embolism syndromes. Every major organ system except the lungs may be directly affected by cholesterol emboli; devastating consequences encompass cerebral, myocardial, spinal cord, intestinal, renal, and other visceral organ infarction, as well as peripheral and perineal gangrene. Additional complications include severe hypertension, gastrointestinal bleeding, and hemodynamic instability. Anticoagulants and thrombolytic therapy may exacerbate atheromatous embolism and are relatively contraindicated. Aggressive supportive therapy may improve chances of survival, but long-term prognosis is poor. Prevention remains the most important aspect in this devastating disorder.
No takes yet. Share an insight, caveat, or question.
Lisa L. Kirkland (1993) conducted a case report in Cholesterol embolism syndromes (n=4). Cholesterol embolism was evaluated. Cholesterol embolism syndromes can cause devastating multi-organ infarction and complications, with anticoagulants and thrombolytic therapy being relatively contraindicated.
Synapse has enriched 10 related papers. Consider them for comparative context: